This audit is based on a thin sample of three 8-K filings over the audit window, and that limitation is itself material — outside readers will notice the absence of periodic 10-Q/10-K filings alongside the specific items disclosed. The most consequential signal is your June 11, 2026 8-K (accession 0001213900-26-067978) reporting an Item 4.02 non-reliance on previously issued financial statements, which is the single highest-scrutiny event a small-cap can file and will anchor every outside read of your disclosure record. Compounding this, your May 28, 2026 8-K (0001213900-26-062172) discloses an Item 3.01 listing-standard notice, and the June 3, 2026 8-K (0001213900-26-064448) reports an Item 2.01 completed acquisition or disposition — a clustering of structurally significant items within roughly two weeks. Short-side and risk-desk readers will read these three filings as a sequence: listing deficiency, transaction, then restatement, and will ask whether the transaction diligence and the restatement scope overlap. Because the underlying 8-K narrative text and exhibit content were not available in the data set provided, several signals below are flagged as borderline pending review of the full filing bodies. The defensive priority before your board call is to have a clean, sequenced narrative that ties the Item 3.01, Item 2.01, and Item 4.02 disclosures together and pre-empts the natural outside inference that they are causally linked.
The combination of an Item 4.02 non-reliance filing, an Item 3.01 listing-standard notice, and an Item 2.01 material transaction within a ~15-day window places disclosure risk above baseline for a small-cap issuer. Individually each item is manageable; in sequence they invite a compounded outside narrative.
Trajectory: worsening — The most recent filing in the window (0001213900-26-067978, June 11, 2026) is the Item 4.02 non-reliance disclosure, which is materially more serious than the preceding Item 3.01 and Item 2.01 filings, indicating the disclosure record deteriorated across the window rather than stabilized.
Your June 11, 2026 8-K reports under Item 4.02, which is reserved for a determination that previously issued financial statements or a related audit report should no longer be relied upon. This is the highest-severity item in the 8-K taxonomy short of bankruptcy and will be the anchor of any outside disclosure review.
Your May 28, 2026 8-K reports under Item 3.01, which covers notice of failure to satisfy a continued listing rule or standard, or transfer of listing. For a Nasdaq-listed small-cap this is typically read as a minimum bid, equity, or filing-delinquency issue.
Three 8-Ks filed between May 28 and June 11, 2026 disclose, in sequence, a listing-standard notice, a completed acquisition or disposition of assets, and a non-reliance determination. The temporal clustering itself is a signal independent of any single item.
Your June 3, 2026 8-K reports an Item 2.01 completed acquisition or disposition of assets, filed eight days before the Item 4.02 non-reliance determination. Outside readers will ask whether the transaction's financial diligence, purchase-price allocation, or pro forma financials sit inside or outside the restatement scope.
Two of the three 8-Ks in the window (May 28 and June 3) invoke Item 8.01 Other Events alongside the primary item. Item 8.01 is voluntary and its repeated use can indicate either proactive transparency or a preference for narrative disclosure outside the more prescriptive items. This is a borderline, non-confirmatory signal.
Only three filings, all 8-Ks, appear in the audit window; no 10-Q or 10-K was captured. This is either a data-scope limitation or a genuine gap, and outside readers will note the same absence in EDGAR. Given the concurrent Item 3.01 and Item 4.02, the absence of a recent periodic report is itself a signal worth pre-empting.
The following questions an analyst is most likely to raise on the next earnings call, with framing suggestions. Each is rooted in a specific filing in the audit window.
The Item 4.02 non-reliance filing (0001213900-26-067978) puts the audit committee squarely in the critical path: outside readers, regulators, and plaintiffs' counsel will expect a documented committee-level determination, a defined restatement scope, and an ICFR reassessment. The committee should be prepared to demonstrate that it, and not solely management, is directing the restatement work and the auditor communications. The proximity to the Item 3.01 listing notice (0001213900-26-062172) and the Item 2.01 transaction (0001213900-26-064448) means the committee should also confirm on the record whether the transaction and the restatement share any subject matter. Any Section 10A auditor communications should be logged and referenced in the minutes.
Board and audit committee minutes should reflect the date of the non-reliance determination, the identity of the initiating party, the scope of periods and accounts affected, and the expected filing vehicle and timeline for the amended reports. The risk register should separately track the Nasdaq listing matter with the specific rule, cure deadline, and remediation options. A written scope memo should document whether the June 3 Item 2.01 transaction is inside or outside the restatement scope, so that this position is defensible on a consistent basis across investor communications, the amended filings, and any subsequent inquiry. Retain all drafts and version history of the three 8-Ks in the audit window under litigation-hold protocols.
The audit window did not surface an ATM or equity distribution agreement, a registered direct or PIPE announcement, an Item 5.02 officer or director departure, an Item 4.01 auditor change, or an Item 1.03 bankruptcy filing. No going-concern language was captured in the available 8-K item lists, though this cannot be fully confirmed without the underlying filing bodies. The absence of an Item 4.01 auditor change alongside the Item 4.02 non-reliance is a mildly positive signal, as combined 4.01/4.02 sequences typically read worse externally.
This audit uses a filings-only methodology based on Form 8-K item taxonomy under General Instruction B and the SEC's Item 1.01 through 9.01 schedule, applied to filings retrieved from EDGAR for CIK 0001963685 over the trailing twelve months. Severity is assigned by mapping each disclosed item to a standard risk weight (Items 4.02, 3.01, 4.01, 1.03, and 5.02 carry the highest baseline weights), then applying an adjacency multiplier when high-weight items cluster within a rolling 30-day window. The overall risk band reflects the weighted item mix, the trajectory across the window, and the presence or absence of mitigating disclosures. This audit does not incorporate stock price, trading volume, short interest, options activity, sell-side analyst notes, message-board sentiment, or any non-public information; it is a disclosure-language read only. Because only three 8-Ks were available and no periodic reports were included in the data set, several signals are flagged as borderline and should be re-run once the underlying filing bodies and the next 10-Q or 10-K/A are available.